Delivery Order SPE2DB25D2203-SPE2DB25FPSFT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of NURTEC ODT 75 mg tablets (quantity 8s) valued at $15,183.65. This firm fixed price delivery order, which is not set-aside, represents a single transaction under the company's broader pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units. This is a firm fixed-price delivery order valued at $27,389.85, with an ultimate completion date of July 15, 2025. The award was made through competitive procedures with no set-aside designation. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $7,823.30. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing indefinite delivery vehicle. The order is scheduled for completion by September 29, 2025, with performance based at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units) with a ceiling value of $11,767.46. This firm fixed-price delivery order, which was not set-aside, represents a competitively awarded transaction and is set to be completed by June 3, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) valued at $14,104.15. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,373.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packaging) under a firm fixed-price contract with a ceiling value of $2,564.82. This is a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $33,103.74. This firm fixed price delivery order, which is not set-aside designated, will be performed at the contractor's Conshohocken, Pennsylvania facility with an ultimate completion date of September 15, 2025. The contract represents a continuation of AmerisourceBergen's...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB25FPSFTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count) with a ceiling value of $2,505.33. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs. The DLA Medical Supply Chain regularly issues delivery orders against this IDC to fulfill pharmaceutical requirements for defense and veteran healthcare systems, with NURTEC ODT (a migraine treatment medication) being one of many therapeutic products available through this framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/26/25 |